Skip to Content
ETFs

Simplify Propel Opportunities ETF

SURI
$--
Today’s Change
-- (--)

Snapshot
*

Inception Date
Feb 07 2023
Expense Ratio
2.51%
Type
Global Diversified
Fund Owner
Simplify ETF
Volume (1m avg. daily)
$599
AUM
$68,357,223
Associated Index
None
Inverse/Leveraged
No
Passive/Active
Active
Fractionable on Composer
No
Prospectus
View

Top 10 Holdings

PAGP
Plains GP Holdings LP - Ordinary Shares - Class A
25.48%
ATHA
Athira Pharma Inc
7.30%
MDGL
Madrigal Pharmaceuticals Inc
5.78%
APLT
Applied Therapeutics Inc
5.05%
REPL
Replimune Group Inc
5.01%
TCRX
Tscan Therapeutics Inc
4.73%
AKRO
Akero Therapeutics Inc
4.45%
MCRB
Seres Therapeutics Inc
4.32%
SAGE
Sage Therapeutics Inc
4.14%
PHAT
Phathom Pharmaceuticals Inc
4.09%
Invest with SURI

What is SURI?

The Fund is an actively managed exchange-traded fund ("ETF"). The Fund's investment adviser Simplify Asset Management Inc. (the "Adviser") collaborates with the Fund's sub-adviser, Propel Bio Management, LLC (the "Sub-Adviser"), to seek to achieve the Fund's investment objective. The Fund concentrates its investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. Each of these industries are commonly categorized within the healthcare sector because they share similar economic features and regulatory constraints. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The Adviser employs a derivatives strategy to partially protect or enhance Fund returns. The Sub-Adviser is responsible for security selection and the Adviser is responsible for trade execution, regulatory oversight of the Fund and the derivatives strategy.

ETFs related toSURI

ETFs correlated to SURI include LABU, XBI, IWC

SURI
Simplify Exchange Traded Funds - Simplify Propel Opportunities ETF
LABU
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares
XBI
SPDR Series Trust - SPDR Biotech ETF
IWC
BlackRock Institutional Trust Company N.A. - iShares Micro-Cap ETF
KJAN
Innovator ETFs Trust - Innovator U.S. Small Cap Power Buffer ETF - January
IWO
BlackRock Institutional Trust Company N.A. - iShares Russell 2000 Growth ETF
ARKG
ARK Investment Management LLC - ARK Genomic Revolution ETF
IBB
BlackRock Institutional Trust Company N.A. - iShares Biotechnology ETF
XPH
SPDR Series Trust - SPDR Pharmaceuticals ETF
VTWG
Vanguard Group, Inc. - Vanguard Russell 2000 Growth Index ETF
UWM
ProShares Trust - ProShares Ultra Russell 2000 2X Shares

What is ETF correlation?

Correlation is a measure of the strength of the relationship between two ETFs. It quantifies the degree to which prices of the two ETFs typically move together.

Here, correlation is measured over the past year with the Pearson correlation coefficient (Pearon’s r), which ranges from -1 to 1.

Using ETF correlations in portfolio and strategy construction

ETF correlations can help you create investing strategies and portfolios. Use them to:

  • •Build a diversified portfolio from uncorrelated or inversely correlated ETFs with the aim of minimizing portfolio risk.
  • •Compare correlated or related ETFs to find one with a lower expense ratio or higher trading volume.
  • •Create an investing strategy that hedges an ETF with an uncorrelated or inversely correlated ETF.

FAQ

SURI is a Global Diversified ETF. The Fund is an actively managed exchange-traded fund ("ETF"). The Fund's investment adviser Simplify Asset Management Inc. (the "Adviser") collaborates with the Fund's sub-adviser, Propel Bio Management, LLC (the "Sub-Adviser"), to seek to achieve the Fund's investment objective. The Fund concentrates its investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. Each of these industries are commonly categorized within the healthcare sector because they share similar economic features and regulatory constraints. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The Adviser employs a derivatives strategy to partially protect or enhance Fund returns. The Sub-Adviser is responsible for security selection and the Adviser is responsible for trade execution, regulatory oversight of the Fund and the derivatives strategy.

Yes, SURI is actively managed. In an actively managed fund, the fund manager makes decisions about how funds are invested. A passively managed fund typically tries to track or follow a market index.

No, SURI is not passively managed. It is actively managed. A passively managed fund typically tries to track or follow a market index. In an actively managed fund, the fund manager makes decisions about how funds are invested.

The 1-month return on SURI is 0.0134%. This is the percent change in the value of SURI over the most recent 1-month period. The 3-month return on SURI is 0.0895%. This is the percent change in the value of SURI over the most recent 3-month period.

ETFs similar to SURI include AOA, AOM, and AOK.

ETFs correlated to SURI include LABU, XBI, and IWC.

ETFs that are inversely correlated to SURI include LABD, SRTY, and TWM.

Disclaimers

*

We show information directly obtained from our data provider, Xignite. Data shown here is provided by Xignite, an unaffiliated third party. Composer believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate.

**

We show information based on calculations performed by Composer using data from our provider. Information provided here is based on calculations performed by Composer using data sourced from Xignite, an unaffiliated third party. Composer believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.